The relationship between day-to-dy changes The present study was designed to investigate the potential interactive and independent effects of ozone (03) and outdoor aeroallergens (pollens and molds) on daily asthma severity. This was carried out using the panel study design, which is characterized by longitudinal analyses of daily data for a panel of asthmatics, with each subject acting as his or her own control. This study was conducted in the small Southern California community of Alpine, California, over an 8-week period from 9 May through 3 July 1994. The time period was selected to maximize both 03 and fungal spore exposures, and followed the peak spring pollen season for the area. This study represents 
Although the importance of aeroallergens as triggers of asthma has been known for many years, particularly among asthmatics with demonstrable allergy (1) , there is a lack ofspecific information on the relationship between the level of exposure to specific aeroallergens and daily asthma status. However, there is a relative abundance of literature concerning the inflammatory responses to respiratory allergens among allergic asthmatics and the importance of anti-inflammatory therapy for the treatment of allergic asthma (2) . The present study focuses on the impact of fungal spores on acute asthma severity, a topic that has not been well investigated. Several (6) (7) (8) (9) .
Additionally, more research has been called for regarding the synergistic or antagonistic effects on asthma status caused by different ambient airborne contaminants including interactions between air pollutants and aeroallergens (10Q.
The present study was designed to investigate the potential interactive and independent effects of ozone (03) and outdoor aeroallergens (pollens and molds) on daily asthma severity. This was carried out using the panel study design, which is characterized by longitudinal analyses of daily data for a panel of asthmatics, with each subject acting as his or her own control. This study was conducted in the small Southern California community of Alpine, California, over an 8-week period from 9 May through 3 July 1994. The time period was selected to maximize both 03 and fungal spore exposures, and followed the peak spring pollen season for the area. This study represents the second in a series of epidemilogic studies utilizing personal passive 03 exposures. The first study found that 12 asthmatic children followed daily for 6 weeks showed notably stronger adverse effects from personal 03 than from outdoor stationary site 03 and found that outdoor airborne fungal spores adversely effected asthma symptom levels and as-needed bronchodilator use (11) . In a recently published 03 modeling study, Liu et al. (12) utilized personal 03 data from the panel of this paper and an additional panel from the fall of 1994 in Alpine; Liu et al. describe prediction models and factors that determine personal ozone exposure levels.
Materials and Methods
Study population and allergy testing. The community targeted by this study was chosen in order to maximize the ability to isolate the independent effect of 0 from particulate air pollutants with which 03 is commonly found to be highly intercorrelated. It is a semirural inland community of Southern California located around the small town of Alpine, whose residents live at or above the base of the air inversion zone (1, 200 feet in elevation). It has had a permanent governmental air pollution monitoring site since 1981, with data showing high levels of transported and locally generated ozone but low levels of particulate air pollution relative to more urbanized regions of the United States (13) .
The study protocols were approved by the institutional review boards of San Diego State University and the Southern California Permanente Medical Group. Informed written consent was obtained from all subjects and one of their legal guardians if they were under the age of 18 years. Recruitment of subjects was done by advertisements and through four schools in the Alpine area in addition to referrals from Articles * Effect of outdoor fungi on daily asthma severity the Kaiser Permanente Health Plan, Inc., Southern California Region, San Diego Area, Department of Allergy. Eligibility criteria of the study included 1) physiciandiagnosed asthma with a minimum history of 1 year; 2) asthma exacerbations during several weeks of the warm seasons (March through October) requiring the use of prescribed asthma medications; 3) ages between 9 and 49 years; 4) a home and school or work address in the Alpine area; and 5) absence of patient/parental or indoor household smoking. After excluding two noncompliant subjects, the study population included 22 symptomatic asthmatics, 9 adults ages 24-46 years and 13 children ages 9-14 years.
Classification of allergy among subjects was based on the presence or absence ofpositive allergen reactivity as assessed using skin prick (epicutaneous) tests (SPT) (Bayer Corp., Allergy Products, Spokane, WA) for various pollens or molds common to the study area (14) . Positive SPT reactivity was defined as a skin wheal greater than 3 mm or with a diameter greater than 50% of a histamine dihydrochloride control while in the presence of a negative saline control. The SPTs for locally relevant pollens consisted of standardized allergen extracts of nine trees, Bermuda grass, one grass mix, and two weed mixes. There were five SPTs for fungal spore taxa: Alternaria alternata ( Outcomes. Within 2 weeks prior to the start of the study, participants were instructed on study procedures and administered a background interview. Subjects were trained and then tested on the proper use of a peak flow meter (Assess, Healthscan Products, Inc., Cedar Grove, NJ). After the start of the study, weekly follow-ups at the subject's homes were done to collect personal 0 passive samplers, to clarify the accuracy ofdiary response information, and to discuss any problems with the study procedures. Daily diary responses were given concerning asthma symptom severity, and three morning and three evening peak expiratory flow rate maneuvers (PEFR) were recorded. Asthma symptoms (cough, wheeze, sputum production, shortness of breath, and chest tightness) were rated by the subjects in terms of their combined severity on a scale from 0 to 5. The six levels of asthma severity were classified as 0, no asthma symptoms present; 1, asthma symptoms present but caused no discomfort; 2 (16) ; however, differences due to face velocity effects and 03 depletion at body surfaces were found (17, 18) . The sampling methodology and validation of these samplers is fully described elsewhere (16) (17) (18) . Continuous monitoring of outdoor ozone was conducted using UV photometry at the SDAPCD site. Weather variables measured at the SDAPCD site included hourly temperature and relative humidity.
Measurements of aeroallergens were made using the Burkard 7-day recording volumetric pollen and fungal spore collector with a sample flow rate of 10 Analytic variables for the total fungal spore and total pollen concentrations were derived by summing the daily concentrations of all identified and unidentified types of these two allergen groups. Other fungal variables were created by summing spore concentrations across genera related to the commonly assessed fungal SPTs as follows: 1) a test fungi variable was the sum of concentrations of each of the five fungal genera represented by the five fungal SPTs; 2) a nontest fungi variable was the total fungal spore concentration minus the test fungi concentration; 3) a positive SPT fungi variable was the sum of fungal spore concentrations of those five genera represented by the five fungal SPTs to which a subject tested positive; and 4) a negative SPT plus nontest fungi variable was total fungal spore concentration minus the positive SPT fungi concentration. The assumption here was that a positive SPT to a fungal extract was an indication of allergy to the genus, although cross-reactivity patterns within single genera have not been fully described and are not likely to be 100%.
Analysis. The analysis began with descriptive statistics, which included time plots for the examination of possible trends in the data. Exposure correlation matrices were constructed to assess the amount of intercorrelation that could imply potential confounding or multicollinearity in the regression analyses.
Regression analyses were based on the general linear mixed model, which estimates both fixed and random effects (SAS MIXED procedure) (19) and is particularly suitable for longitudinal data analysis of serially correlated data in individuals (20) . The SAS MIXED procedure optimizes a restricted maximum likelihood (REML) function by using the Newton-Raphson algorithm (19, 21 (19) was used to assess the fit of the various mixed models having the same fixed effects, but with versus without modeling autocorrelation of the residual error terms. It was consequently found that the best models included first order autoregressive parameters to control for significant autocorrelation of residual errors. In addition to examining the relationship of asthma responses to same day exposures, levels of environmental factors were lagged 1 day prior to the day in which the diary was completed and compared to response levels to account for delayed effects.
Although symptom scores and as-needed n-agonist inhaler doses are ordinal outcome variables with non-normal distributions, residual errors from regressions using these ordinal variables in the models were found to be approximately normal, as indicated by normal probability plots and means of zero. In the regression analyses, maximum temperature and average relative humidity were examined for confounding and interaction, and days of the week trends in the outcome and environmental variables were tested to assess potential bias in the estimation of effects.
The estimates of effect were rescaled to represent the effect of a multiple unit change in exposure in its daily concentration (e.g., change in PEFR per increase of 100 ppb 03). Standard errors of these estimates are also given. For the individual fungal types (e.g., Altemnaria), this scale reflects the effect at the 90th percentile of the distribution for that fungal variable (i.e., the difference between the upper decile and the minimum concentration). This will allow a standardized view of effects for the fungal concentration ranges measured in this study. These effect estimates will be referred to in this paper as 90th percentile effects. Since 
Results
Outcomes. The characteristics of the 22 subjects are shown in Table 1 . Subjects in this study were using a variety of as-needed n-agonist inhalers and daily prescribed medications, and 11 subjects took only asneeded 3-agonist inhalers. Percent predicted PEFR (23, 24) calculated from the average evening PEFRs were below 88% for both the pediatric and adult groups. There was little difference overall between the average levels of evening and morning PEFR, with a diurnal difference of only 3% higher levels in the evening than in the morning. Sixteen subjects were allergic to at least one of the five fungal SPTs; of these, all were allergic to Alternaria, and three were only allergic to Alternaria. All nine subjects allergic to Aspergillus were also allergic to Penicillium, but two subjects were allergic to Penicillium but not Aspergillus. This is important in the analysis of effects of these two spore types on the asthma outcomes, including the positive SPT variable, since Penicillium spores cannot be distinguished from Aspergillus under the microscope. This required that responses from all 11 subjects be regressed on the summed concentrations of Aspergillus and Penicillium. All subjects were SPT positive to at least one pollen extract and 16 subjects were allergic to one or both dust mite antigens (Derfand Derp). Daily diaries were obtained for a total of 1,218 person-days of observations from a possible 1, 250 person-days. During this 8-week study, noncompliance with diary completion accounted for 32 person-days. There were 1,152 person-days of observation for asthma symptoms and 883 persondays of observation for as-needed n-agonist inhaler use. There were two subjects who only took prescribed inhalers daily (beclomethasone dipropionate) and did not use as-needed ,-agonist inhalers (subjects 1 and 18, Table 1 ), accounting for 112 days not induded in the analysis of as-needed 3-agonist inhaler use. The remaining observations unavailable for analysis were in error or missing largely because subjects failed to enter a zero and, instead, left the field blank, despite repeated instructions to enter zeros if there were no symptoms or if they did not require as-needed ,B-agonist inhalers. Subjects were not allowed to recall events more than 1 day in the past; therefore, blank observations were considered missing. There were a total of 1,114 person-days of observation for morning PEFR and 1,107 person-days of observation for evening PEFR, with most of the remaining missing observations (104 and 111 persondays, respectively) for times when subjects did not perform maneuvers or made invalid entries. All of the PEFR data was invalidated for one subject who frequently did not perform the peak flow maneuvers properly despite retraining (subject 3, who used the spitting technique rather than a forced expiratory maneuver over several seconds).
There were no significant day-of-week trends in any of the outcome variables, but asthma symptom scores and as-needed inhaler use were slightly lower on average for Saturdays than for the rest of the week (p<O. 12). Inclusion of a day-of-week indicator variable in the regression models for these variables did not confound any of the associations reported below. Also, all three of the outcomes were significantly worse during the reported presence versus absence of respiratory infections on 43 versus 1,094 person-days of observation, respectively (p<0.02). However, none of the associations reported below were confounded by the presence of respiratory infections.
Correlations between the three outcomes were tested with Spearman's rank correlation. The correlation of PEFR to both asthma symptom scores and as-needed (Table 2) . We believe that these high measurements represent laboratory or analytic error because they are higher than outdoor concentrations and they were sampled during weekdays when subjects spent a majority of time indoors. In fact, after removing these in our ozone modeling study noted above, the expected higher concentrations on the weekends than on weekdays became clearer because subjects spent higher fractions of time outdoors on A correlation matrix for the air pollutant, summed aeroallergen, and weather variables is presented in Table 3 . There were several modest but statistically significant correlations of the air pollutants (PM1O and 03) with the aeroallergens (total pollen and total fungal spores), suggesting a potential for aeroallergens to confound or modify associations between air pollutants and respiratory health outcomes, or vice versa. This was due in large part to shared meteorological determinants with higher levels of these variables during warm, dry weather, although many fungi in the region of study, particularly the ascomycetes and basidiomycetes (14) , sporulate during damp, cool periods when pollution levels are lower. Correlations of the outdoor environmental variables to personal 03 exposure measurements were low, again suggesting that personal activity patterns such as indoor residence time dominated the exposure profile (12) .
The basidiomycetes and ascomycetes were not significantly correlated with the remaining nontest spores as a group or with the test fungi variable (p>O.1 5). Table 4 shows a correlation matrix for the specific fungal types examined, which further supports this finding. A small correlation was found between basidiospores and ascospores (R = 0.35) and between basidiospores and one of the deuteromycetes, Botrytis. The deuteromycetes (Periconia, Botrytis, and the five test fungi) were moderately correlated with each other in general. Two test fungi (Alternaria and Cldsporium) were moderately correlated to hyphal fragments, rusts, and unidentified spores with the exception of Cladosporium and rusts. Higher levels of ascomycetes and basidiomycetes were found during the cooler, damper period during the first 3 weeks of the study, which contributed to a lack of temporal correlation with the other spore types, many of which like the deuteromycetes of Alternaria and Cladosporium sporulate in response to low humidity (25) .
Regression models, symptom severity. A major determinant of symptom severity was maximum temperature, with hotter temperatures being associated with lower symptom levels ( bFungal spore concentrations of those five genera represented by the SPTs, namely, Alternaria, Helminthosporium, Cladosporium, Aspergillus, and Penicillium. cTotal fungal spore concentration minus the five genera represented by SPTs. dFungal spore concentration of those five genera tested to which subjects showed a positive SPT. eTotal fungal spore concentration minus the concentrations of the five genera tested to which subjects showed a positive SPT.
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Articles -Delfino et al. dropped below 530F. Total fungal spore concentrations were positively associated with asthma symptom scores, and the magnitude of the relationship was greater when controlling for temperature (Table 5 , model C). The remaining models in Table  5 Figure 1 .
The analysis was then restricted to the 16 subjects with a positive SPT to at least one of the five fungal genera tested. The largest parameter estimate was found for positive SPT fungi, as opposed to total spore concentrations or to negative SPT plus nontest fungi. However, differences were small and the standard error of the estimate was larger 
O- and involve exposures on the same day as PEFR measurements (I/min) in 21 subjects, or the same day for which the number of inhaler puffs were reported in 20 subjects; regression models C-E for PEFR controlled for maximum temperature (OF) and regression models I-K for inhaler use controlled for mean relative humidity (%).
bFungal spore concentrations of those five genera represented by the allergy skin prick tests (Altemaria, Helminthosporium, Cladosporium, Aspergillus, and Penicillium).
cTotal fungal spore concentration minus the five genera represented by skin prick tests.
for the positive SPT fungi (Table 5 , model G vs. models F and H, respectively). There were no significant effects of fungal spores (induding total, test, and nontest fungi) on asthma symptom scores in models induding the six individuals with negative SPTs for the five fungal taxa (p<0.2; models not shown).
The analysis was further subdivided into pediatric and adult groups. Again, for both age groups, the largest parameter estimate was for positive SPT fungi, but higher standard errors were also found (Table 5 , models J and M). The largest parameter estimate of any of the models for fungi in Table 5 Articles -Effect of outdoor fungi on daily asthma severity SPT fungi (-5.5 l/min/1,000 spores), as compared with total spore concentrations (-2.8 1/min/1,000 spores). However, these effects were borderline statistically significant (p<0.08). There were no significant effects of fungal spores on PEFR in a group analysis of the six individuals with negative SPTs for fungi. A subset analysis of the effect of fungal spore concentrations on PEFR among pediatric and adult groups showed that although nearly all parameter estimates were negative, the only statistically significant model was for the effect of total fungal spore concentrations on pediatric subjects (-3.1 l/min/1,000 spores; p<0.05).
Similar to results for symptoms, there were no associations of morning or evening PEFR to total pollen, Adenostoma pollen, personal 03, stationary site outdoor 03, or PM10. No interaction or confounding between these environmental variables and fungal spores or weather variables was found in relation to PEFR.
Regression models, as-needed inhaler use. As-needed 3-agonist inhaler use varied inversely with maximum temperature (Table 6 , model F; -0.1 puffs/10°F; p<O. 14) and positively with average relative humidity (0.07 puffs/10%; p<0.06). The magnitude and statistical significance of an association between inhaler use and total fungal spore concentrations alone was greater when controlling for relative humidity (Table 6 , model I vs. model H) or for temperature. Inclusion of temperature in the regression did not improve the fit of the model as well as humidity. The magnitude of the association to inhaler use was similar for test fungi and nontest fungi, but only the test fungi were statistically significant (Table 6 , models J and K). For an increase of 1,000 test fungal spores/m3, inhaler use increased by 0.16 puffs (p<0.02).
A subset analysis of the 16 fungal allergic subjects again showed the largest effect estimate from positive SPT fungi (0.20 puffs/1,000 spores/m3; p<0.07), although the p-value was smaller for total spore concentrations (0.1 1 puffs/ 1,000 spores/m3; p<O.001). There were no significant associations between inhaler use and fungal spores in the six individuals with negative SPTs for the five fungal taxa (p<0.5). The only statistically significant effects on inhaler use among adults were for positive SPT fungi on the 6 fungal allergic adults (0.44 puffs/1,000 spores/m3; p<0.05). However, the largest effect on inhaler use in the pediatric group was for negative SPT plus nontest fungi among the fungal allergic (0.36 puffs/1,000 spores/m3; p<0.003) as compared to total spore concentrations for either all children or fungal allergic children (0.14 and 0.17 puffs/1,000 spores/m3, respectively; p<0.02). The lower 95% confidence limit for negative SPT plus nontest fungi just includes these point estimates for total fungi (0.12-0.59/1,000 spores/m3). Unlike results for asthma symptoms, positive SPT fungal concentrations were not significantly associated with inhaler use among pediatric subjects (p<0.37).
Total Regression analysis of individualfungal types. To assess the potential effects of the different types of test and nontest fungi on asthma status, regression models for each of the three outcomes included the following fungal types: 1) each the five separate SPT fungi except Aspergillus and Penicillium, which had to be combined as discussed above; 2) total basidiospores; 3) the major identified basidiospore, Coprinus, 4) total ascospores; and 5) the major nontest spores other than the basidiospores or ascospores (the deuteromycetes Periconia and Botrytis, hyphal fragments, rusts, and unidentified taxa). Regressions for each of the five test fungi involved subjects allergic to the spore type, whereas regressions for the nontest fungal types involved all 22 subjects (Table 7) . One extreme outlier for the basidiospores due to gastromycete contamination discussed above and two high ascospore oudiers >677 spores/m3 (>8 times the interquartile range) were excluded from the regression analysis because they had a great influence on parameter estimates and residual errors and led to negative results for basidiospores and unexpected significant inverse associations for ascospores. The same was found for one Periconia outlier (402 spores/m3; >5 times the interquartile range), which when included in regressions, halved the regression parameter estimates.
The magnitudes of effect on all three outcomes by Alternaria and Helminthosporium were notably greater than the other test spores Cladosporium and AspergillusPenicillium when estimates of effect were Effects offungi. This is the second in a series of asthma panel studies by the present group of investigators, who are using longitudinal data analysis to examine the relationship between daily asthma status and outdoor fungal concentrations. Although the first study was conducted in a climatologically different region (coastal vs. inland San Diego county) and season (fall vs. late spring), results were consistent with the present findings regarding the effect of total fungal spore concentrations on symptom scores and on inhaler use (11) . However, in the previous study, a greater magnitude of response for positive SPT fungal concentrations in comparison to total fungi was found only for inhaler use and not for asthma symptom score. Similar effect levels were found for the two studies for both asthma symptoms and inhaler use in relation to concentrations of fungi, which were not included in the SPT battery (same five fungal taxa used). This was exemplified by the effect of basidiospores on asthma symptoms among the 12 pediatric subjects in the previous study (symptom scores increased by 1.2/1,000 fungal spores/m3; p<O.07). Sample size, cohort, geographical, or seasonal factors may explain the few differences in results between the two studies, suggesting the need for additional longitudinal studies in more climatologically diverse areas in order to generalize the present findings to other populations of susceptible asthmatics.
Few other cohort studies have been directed at determining the importance of fungi to daily asthma severity, and results from those studies are limited. Klabuschnigg and colleagues (3) examined data collected daily from 40 asthmatics over a 6-week period in an Austrian summer camp. The authors graphically showed a relationship of asthmatic complaints to pollen and to Cladosporium concentrations; however, no statistical analyses were presented. Another study in the Netherlands involved measurements of colony-forming units of fungal spores outside of the homes of eight fungal allergic asthmatics; measurements were taken approximately once per month rather than on sequential days (4). This study showed significantly lower average PEFR on days when fungal spore concentrations were highest versus the lowest days (mean PEFR 354 vs. 400 1/min, respectively; p<O.05).
Many fungal spores are capable of reaching the conducting airways of the lungs, and some have been found to produce inflammatory effects on the respiratory mucosa of allergic asthmatics, as demonstrated in bronchoalveolar lavage studies (26) . Indirect evidence of allergic IgE-mediated responses to fungi was provided by Licorish et al. (27) who performed bronchial challenges on seven young adults with mild asthma using either Alternaria or Penicillium spores, depending upon the patient's allergy (approximately 2,000 and 10,000 spores/mi3, respectively). Pulmonary function tests and clinical symptoms were consistent with both immediate and late onset asthmatic responses. Compared to other allergens, the relative importance of fungal spores with respect to IgE-mediated responses among allergic asthmatics is not known. Results of several successful experimental trials of mold immunotherapy suggests that fungal antigens are clinically important (22) . The threshold concentration for inducing an asthmatic response by any fungal species is also unknown, but it is likely to vary based upon individual sensitivity and fungal species (22) . The present study supports this view because results showed greater magnitudes of response when the fungal-specific allergies of the individual were accounted for and the magnitude of response per concentration of spores varied depending upon the spore type (e.g., basidiomycetes). The possibility that fungal allergens may have more potent effects in susceptible individuals compared to other allergens is supported by a study which examined 11 asthmatics seen at the Mayo clinic who had one or more episodes ofrespiratory arrest during the period [1980] [1981] [1982] [1983] [1984] [1985] [1986] [1987] [1988] [1989] (5) . Ten of these asthmatics were both skin test positive for Alternaria and had their respiratory arrest during the Alternaria aeroallergen season of summer and early fall. Consistent with this is data from an ecological study conducted in Chicago, Illinois, during the period May to October from 1985 to 1989 that showed the odds of death from asthma for 67 asthmatic patients ages 5-34 years were twofold higher on days when fungal spore concentrations were at or above 1,000 spores/m3 versus days below 1,000 spores/m3 (95% CI, 1.31-3.56) (28) .
The effect estimates for the population sample in the present study were in most cases relatively small, given the range of fungal spore concentrations measured (655-6,110 spores/m3). This was particularly evident for PEFR deficits, which were in most cases not more notable than -10 1/min for a 90th percentile increase in any of the fungal types ( (32) clearly demonstrated the allergenicity of basidiospores among asthmatics by finding positive SPTs to basidiospores in 30% of 339 asthmatics, as compared with only 18% of 343 subjects without asthma (p<0.005). In one study, 8 asthmatics with both positive skin test reactivity and positive radioallergosorbent test to basidiospores showed a positive bronchoprovocation challenge with basidiospores, while 6 atopic asthmatics with negative basidiospore tests had negative challenges; both groups had similar levels of methacholine reactivity (33) . Additional evidence for the importance of the basidiospores has been shown by increased asthma hospital admission and emergency room visit rates during outdoor peaks of basidiospore concentrations (6, 8, 9) . Another issue of concern regarding the present study is that although many of the fungal taxa not represented in the SPT battery, such as the basidiospores, could be microscopically identified in the present study, a large proportion of the total spore concentration was comprised of unidentified taxa (mean 717 spores/m3), which were significantly associated with PEFR and inhaler use (Table 7) . Finally, allergy testing used in this study, namely epicutaneous skin punctures, can produce false negatives. Confirmatory intradermal skin tests for negative epicutaneous tests would improve sensitivity but can produce false positive results. It is possible that a battery of fungal allergy tests larger than that used in the present study could still miss etiologically important fungal allergens carried by other fungal taxa. This is consistent with a published finding that the association of asthma to allergen skin test reactivity using only 18 allergens (pollens, molds, and dust) was notably weaker than the association between serum IgE level and asthma (1) .
Effects of air pollution and pollen. There was almost no effect of air pollution on the asthma outcomes in the present study. The Results from the previous asthma panel study discussed above contrast the present negative findings for 03 (11) . The previous study was conducted in an urban area of San Diego county and showed positive associations of daily asthma severity to personal 03 exposure levels that were somewhat lower than those in the present study (11) . For the 12 subjects followed over 6 weeks in that study, a 90th percentile increase in personal 03 (25 ppb 12-hr average) led to a 25% increase in mean symptom scores (95% CI, 0-49%) and to a 26% increase in mean inhaler use (95% CI, 3-48%). The population for the present study was a semirural community of San Diego county located at the inversion layer base, typically having relatively high outdoor 03 and low particulate air pollution levels. Given this, it is possible that joint exposure to modest elevations of 03 in combination with other air pollutants common in urban environments may be etiologically important to adverse respiratory effects among asthmatics.
There is another factor that may have contributed to differences in results: the inland area of the present study generally experiences daily maximum temperatures that are 10-20°F higher than the coastal communities of San Diego county represented by the former study. The use of air conditioners is therefore considerably more frequent in Alpine than in the coastal area, as evidenced in the activity diaries of subjects (12) and reports by the Alpine school teachers of the pediatric subjects. None of the subjects in the previous study used air conditioning in their homes, as compared to 86% in the Alpine study. We also found no effects of temperature in the previous study, but in the present study, we found unusually strong protective effects of higher temperature on symptoms, PEFR, and as-needed inhaler use. Rather than a direct protective effect of temperature, it is more likely that higher temperatures were driving a decrease in personal allergen exposure due to filtration of indoor allergen particles (including particles carrying dust mite antigens) from refrigerative air-conditioning through precipitation in removed water (34) and the inhibitory effects of cool dry air on indoor fungal growth and sporulation (35) . Short-term temporal changes in indoor airborne particulates related to the onset of hot, dry weather could also occur as a result of changes in air exchange rates, physical disturbance from increased indoor residence time, and changes in the aerodynamic properties of particles. Although cool, dry air resulting from refrigerative air-conditioning is expected to inhibit indoor dust mite growth (36) , this would likely occur over longer seasonal time periods. For instance, the warm, dry period after 26 May in the present study would be expected to gradually diminish indoor dust mite numbers over the remainder of the study. Antigenic particles from dust mites, on the other hand, could still persist in household reservoirs such as carpeting and furniture. However, the literature on day-to-day changes in airborne dust mite antigen exposure is incomplete, and we are not aware of any published research that has examined the relationship of asthma severity to daily personal exposure to airborne allergens. The approach to measuring personal dust mite antigen exposures has been recently presented in the literature, although the methods are not well defined (37) .
Because 03 is maximally generated by sunlight and is strongly and positively correlated to temperature, the indirectly protective effect of hot dry weather on allergen-induced asthma could have overwhelmed any of the suspected effects of 03 on airway caliber or inflammation among asthmatics (38) . Such an effect should be kept in mind in studies examining the effect of air pollutants on asthma morbidity, particularly when meteorological factors are used as control variables. Also, small but significant intercorrelations between aeroallergens and air pollutants were found in the present study ( Outcome misclassification in diary studies is an additional source of error due to a lack of truly verifiable patient data. This can occur through a lack of subject compliance (invalid PEFR maneuvers, falsified records, and distant recall), an issue that has plagued asthma diary studies to the present (39, 40) . Data quality could be greatly improved by the use of subnotebook diaries, nebulizer chronologs, and forced expiratory volume in 1 sec (FEV1)/PEFR monitors that are electronic and time-date stamped, but these alternatives are costly.
The alternative to the above-mentioned approaches of personal exposure measurements and verifiable response data that is often used in epidemiologic studies is to enhance statistical power by increasing sample size, which can overwhelm methodological inaccuracy and interindividual variability. However, a considerable amount of biological information is lost in the bargain. Although much of this mechanistic information can be provided by experimental studies, it is difficult to extrapolate the experimental conditions to conditions in natural settings. The present repeated-measures design actually enhances power because the sample size was not simply 22 subjects, but was the person-days of observation, which for symptom scores and fungi was 1,100.
The repeated measurements in each subject allowed analyses to be performed on each individual. The present panel design shares similar features to the cross-over dinical trial in that both study designs are statistically efficient (enhanced signal-to-noise ratio) because multiple treatment conditions (or exposures) are studied in each subject and variability in exposure-response relationships due to between-subject characteristics is controlled for by design (41) . The last advantage is due to a reduction in the variability of the response variable without reductions in the magnitude of the exposure-response relationship, thereby enhancing power and precision (42) . Nevertheless, intra-individual temporal variation due to measurement error is a major limitation. Although many subjects showed statistically significant effects from fungi, particularly for symptoms among the pediatric subjects and basidiospores, it is probably not justified at this point to call them responders and the others nonresponders. Presenting doseresponse information on each individual is an important task for an experimental study or clinical trial. However, this is a nonexperimental epidemiologic study, which has limited power to examine effects in individual subjects. The primary limitation relates to the fundamental difference between experimental versus nonexperimental epidemiologic (observational) studies: the investigator in a nonexperimental study does not have control over the conditions of exposure, induding reduction in the variation ofextraneous factors in comparison with the factor of interest (43) . One major consequence of this is the difficulty of accurately assessing the conditions of exposure, which leads to exposure misclassification and inflation of random error. This in turn diminishes the statistical power to detect an effect. In the present study there is, by the nature of its design, insufficient accuracy in the assessment of the conditions of exposure to declare that any individual regression analysis is valid for the subject. Nevertheless, we have presented individual autoregressions and, while marginal or significant effects (p<O.1 or p<0.05) are seen for certain individuals, this should not be interpreted as more indicative of an adverse effect among those particular individuals. The expected lack of clear heterogeneity of effects from individual regressions as compared with population averaged effects was previously shown in similar studies by Neas et al. (44) who described a panel study of daily respiratory effects of air pollutants; Hoek et al. (45) who used four repeated pulmonary function tests in children; and a reanalysis of three summer camp studies of air pollution and pulmonary function (46) . Brunekreef et al. (46) provided evidence that the variability of individual regression slopes may be largely due to within-subject variability rather than between-subject variability. One general solution to this issue is to advance the field of air pollution epidemiology by improving methods of repeated measurement studies in a manner that provides a view of temporal effects in individual subjects with a minimum of exposure and outcome misclassification. This paper, its companion paper by Liu et al. (12) described above, and our previous asthma panel study (11) , represent an advancement in this direction because they are among the first to use daily personal ozone measurements over long periods.
Another issue that emerges from the present results is that effects of fungal spores were not entirely consistent across the three asthma outcomes. Given the low to modest intercorrelations between the response variables reported above, it is expected that exposures associated with one outcome may not be associated with the other outcomes. Differences in estimates of effect across the outcomes are probably a reflection of both the utility of multiple asthma outcomes and how interindividual variability contributes to such differences in results. For instance, PEFR provides information about physiological changes in response to agents that may not be detected with symptom reports, particularly since some asthmatics appear to be poor perceivers of bronchoconstriction (47) . On the other hand, the symptom scoring system we use allows the asthmatic to gauge his or her daily quality of life resulting from asthma, whereas lung function measurements such as PEFR represent a snapshot of one physiological parameter, which may not be representative of the daily severity of asthma. This underestimate of asthma severity by PEFR is particularly likely if the patient has been using as-needed 13-agonist inhalers throughout the day or prior evening. The use of inhalers, in turn, is expected to vary between individuals based upon their perception of asthma severity and knowledge of, and compliance with, appropriate inhaler use.
Implications. The findings from this study suggest that elevations in outdoor fungal spores may adversely affect symptom severity, medication use, and lung function of asthmatics. This is the second in a series oflongitudinal studies to show that outdoor levels of particular fungal spore types are associated with daily asthma status to different degrees depending upon the genus-specific fungal allergy of the individual. The effects of fungal spore concentrations were generally greater among individuals having skin prick sensitivity to common fungal spore allergens. However, many exceptions were found that suggested a more complex and diverse pattern of fungal allergy among asthmatics. If skin prick allergy testing was expanded to a wider variety of fungal taxa, these simple and well-tolerated tests could be used to stratify large numbers of individuals in epidemiological studies in order to examine the effect of relevant aeroallergen levels and their interactive influence with other cofactors such as air pollutants. The present findings suggest that further longitudinal investigations of asthma determinants are warranted involving both allergy testing and aerometric measurements for a wide range of fungi, pollen, and indoor allergens. Advancements in the methods of exposure assessment for airborne allergens is urgendly needed for such investigations to be carried out. Available tools and methodologies from air pollution research can and should now be applied to this task.
